M
Mereo BioPharma Group plc (MREO)
NCM – Real Time Price. Currency in USD
0.30
-0.00 (-1.46%)
At close: Jun 26, 2026, 4:00 PM EDT
0.30
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.30
-0.00 (-1.46%)
At close: Jun 26, 2026, 4:00 PM EDT
0.30
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:59 PM EDT
No Data
There are no news for this stock.
Cash reserves $36.2M barely cover the upcoming debt maturities $0.0
Total current assets $40.0M exceed Total current liabilities $6.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$4.3M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.48 | 6.05 | 10 | |
| Quick ratio | 6.48 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 10M | N/A | 501K | 506K |
| Gross Profit | 257K | 6M | -1M | -784K | -825K |
| Operating Income | -54M | -29M | -47M | -41M | -38M |
| Net Income | -42M | -30M | -43M | -42M | -36M |
| EBITDA | -53M | -27M | -46M | -39M | -37M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 366.67 | 29.7 | 10 |
| Next quarter | -100 | -56.2 | 1.0 |
| Current year | 2755 | 76.67 | 10 |
| Next year | 90.01 | 32.68 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 8.62 | 0 | 43.88 | 6.8 |
| Y/Y | 999 | 48.15 | 50 | 48.64 | 10 |
| 3y average | 632.67 | -4.49 | 4.18 | 1.81 | 4.5 |
| 5y average | 559.4 | -49.16 | 19.67 | -81.19 | 5.3 |
| Weighted average score | 6.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |